We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
Cap. Flow
+$224M
Cap. Flow %
1.06%
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$211M
2
ABBV icon
AbbVie
ABBV
+$176M
3
AAPL icon
Apple
AAPL
+$170M
4
NKE icon
Nike
NKE
+$161M
5
KO icon
Coca-Cola
KO
+$141M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$221M
2
MDT icon
Medtronic
MDT
+$163M
3
UNH icon
UnitedHealth
UNH
+$148M
4
JNJ icon
Johnson & Johnson
JNJ
+$133M
5
PFE icon
Pfizer
PFE
+$126M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 14.98%
3 Healthcare 13.91%
4 Financials 10.93%
5 Industrials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARGX icon
1351
argenx
ARGX
$53.6B
-19,150
Closed -$7.13M
ARRY icon
1352
Array Technologies
ARRY
$796M
-720,623
Closed -$15.8M
ASRT
1353
DELISTED
Assertio
ASRT
-5,816
Closed -$556K
AVT icon
1354
Avnet
AVT
$7.87B
-9,810
Closed -$443K
AX icon
1355
Axos Financial
AX
$5.72B
-24,121
Closed -$891K
BAX icon
1356
Baxter International
BAX
$14B
-1,154,723
Closed -$46.8M
BDC icon
1357
Belden
BDC
$5.36B
-5,408
Closed -$469K
BEN icon
1358
Franklin Resources
BEN
$17.2B
-36,007
Closed -$970K
BHC icon
1359
Bausch Health
BHC
$2.37B
-65,888
Closed -$534K
BIDU icon
1360
Baidu
BIDU
$35.5B
-116,002
Closed -$17.5M
BIIB icon
1361
Biogen
BIIB
$31.1B
-1,890
Closed -$525K
BLMN icon
1362
Bloomin' Brands
BLMN
$924M
-102,178
Closed -$2.62M
BLUE
1363
DELISTED
bluebird bio
BLUE
-52,612
Closed -$3.35M
BMO icon
1364
Bank of Montreal
BMO
$129B
-32,258
Closed -$2.87M
BPMC
1365
DELISTED
Blueprint Medicines
BPMC
-41,352
Closed -$1.86M
BPOP icon
1366
Popular Inc
BPOP
$11.3B
-162,331
Closed -$9.32M
BPT
1367
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
-71,343
Closed -$545K
BR icon
1368
Broadridge
BR
$19.6B
-30,031
Closed -$4.4M
BTAI icon
1369
BioXcel Therapeutics
BTAI
$34.9M
-2,160
Closed -$645K
BWA icon
1370
BorgWarner
BWA
$13.8B
-139,380
Closed -$6.03M
BXMT icon
1371
Blackstone Mortgage Trust
BXMT
$2.44B
-312,165
Closed -$5.57M
CAKE icon
1372
Cheesecake Factory
CAKE
$5.57B
-44,149
Closed -$1.55M
CARR icon
1373
Carrier Global
CARR
$52.2B
-205,824
Closed -$9.42M
CASY icon
1374
Casey's General Stores
CASY
$31.6B
-8,591
Closed -$1.86M
CBRE icon
1375
CBRE Group
CBRE
$44B
-168,258
Closed -$12.3M

Similar funds

Voloridge Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
  • Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
  • Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
  • Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
  • Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
  • Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
  • Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.